Literature DB >> 19344718

Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction.

Aurélien Amiot1, Maya Tchikviladzé, Francisca Joly, Abdelhamid Slama, Dominique Cazals Hatem, Claude Jardel, Bernard Messing, Anne Lombès.   

Abstract

BACKGROUND & AIMS: Chronic intestinal pseudo-obstruction (CIPO) is a rare disorder caused by intestinal dysmotility and characterized by chronic symptoms suggesting bowel obstruction in the absence of fixed, occluding lesions. CIPO has been associated with primary defects of the mitochondrial oxidative phosphorylation pathway, although the frequency of mitochondrial disorders in patients with CIPO is unknown. This study evaluates mitochondrial function in patients with CIPO.
METHODS: A retrospective study was performed of data collected from 80 CIPO patients at a tertiary centre over a 25-year period. Mitochondrial disorders were detected by analysis of serum lactate and thymidine phosphorylase activities, brain magnetic resonance images, and muscle biopsies. Genes encoding thymidine phosphorylase, mitochondrial DNA tRNA(leu(UUR)) or tRNA(lys), and DNA polymerase-gamma were analyzed for mutations.
RESULTS: Mitochondrial defects were identified in 15 patients (10 women; median age at diagnosis 32 years), representing 19% of the study cohort. All 15 patients had extra-digestive symptoms, 5 had mutations in the thymidine phosphorylase gene, 2 had mutations in tRNA(leu(UUR)), and 5 had mutations in the DNA polymerase-gamma gene. No genetic defect was detected in 3 of the patients with mitochondrial disorders. Patients with mitochondrial CIPO differed from patients without mitochondrial defects in their very severe nutritional status (frequent and long-term requirement for parenteral nutrition) and poor prognosis (frequent digestive and neurologic complications that led to a high incidence of premature death).
CONCLUSION: Mitochondrial disorders seem to be an important cause of CIPO. Patients with CIPO, especially severe cases with associated neurologic symptoms, should be tested for mitochondrial defects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344718     DOI: 10.1053/j.gastro.2009.03.054

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

Review 1.  Mitochondrial genetic diseases.

Authors:  Marni J Falk; Neal Sondheimer
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

2.  Diagnosis of Chronic Intestinal Pseudo-obstruction and Megacystis by Sequencing the ACTG2 Gene.

Authors:  Aubrey Milunsky; Clinton Baldwin; Xiaoying Zhang; Daniel Primack; Adrian Curnow; Jeff Milunsky
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

3.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations.

Authors:  Sha Tang; Elliot L Dimberg; Margherita Milone; Lee-Jun C Wong
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

4.  Characteristics of intestinal pseudo-obstruction in patients with mitochondrial diseases.

Authors:  Yusuke Sekino; Masahiko Inamori; Eiji Yamada; Hidenori Ohkubo; Eiji Sakai; Takuma Higurashi; Hiroshi Iida; Kunihiro Hosono; Hiroki Endo; Takashi Nonaka; Hirokazu Takahashi; Tomoko Koide; Yasunobu Abe; Eiji Gotoh; Shigeru Koyano; Yoshiyuki Kuroiwa; Shin Maeda; Atsushi Nakajima
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

5.  Diagnosis of mitochondrial neurogastrointestinal encephalomyopathy: proposal of a clinical algorithm.

Authors:  Vincent Zimmer; Michio Hirano; Anna Zimmer; Frank Lammert
Journal:  Dig Liver Dis       Date:  2014-04-13       Impact factor: 4.088

Review 6.  Mitochondrial disease in childhood: nuclear encoded.

Authors:  Amy C Goldstein; Poonam Bhatia; Jodie M Vento
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

7.  Volvulus as a complication of chronic intestinal pseudo-obstruction syndrome.

Authors:  Carlijn T de Betue; Doeke Boersma; Matthijs W Oomen; Marc A Benninga; Justin R de Jong
Journal:  Eur J Pediatr       Date:  2011-09-23       Impact factor: 3.183

8.  Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

Authors:  Richard E Frye; Shannon Rose; John Slattery; Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-07

9.  Yeast model analysis of novel polymerase gamma variants found in patients with autosomal recessive mitochondrial disease.

Authors:  Magdalena Kaliszewska; Jakub Kruszewski; Biruta Kierdaszuk; Anna Kostera-Pruszczyk; Monika Nojszewska; Anna Łusakowska; Joel Vizueta; Dorota Sabat; Dorota Lutyk; Michał Lower; Dorota Piekutowska-Abramczuk; Aneta Kaniak-Golik; Ewa Pronicka; Anna Kamińska; Ewa Bartnik; Paweł Golik; Katarzyna Tońska
Journal:  Hum Genet       Date:  2015-06-16       Impact factor: 4.132

10.  Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination.

Authors:  Yi Shiau Ng; Catherine Feeney; Andrew M Schaefer; Carol Ellen Holmes; Paula Hynd; Charlotte L Alston; John P Grady; Mark Roberts; Mellisa Maguire; Alexandra Bright; Robert W Taylor; Yan Yiannakou; Robert McFarland; Doug M Turnbull; Gráinne S Gorman
Journal:  Ann Neurol       Date:  2016-09-19       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.